Related Experiment Video
Updated: Jun 24, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Regulation of adiponectin receptor 2 expression via PPAR-alpha in NIT-1 cells
Tae Woo Jung1, Myung Won Lee, Yong Jik Lee
1Samsung Biomedical Institute, Seoul, Korea.
Abstract:
Adiponectin receptors mediate the antidiabetic effects of adiponectin. Although suggested to be mainly expressed in muscle, liver, and adipocyte cells, the expression of adiponectin receptors in beta cells is unclear. Given the primary involvement of this cell type in diabetes mellitus, we presently examined the expression level of adiponectin receptor 2 (AdiR2) in beta cells. Expression was significantly increased under acute hyperlipidemic conditions but impaired under chronic conditions. The impaired AdiR2 expression may play a role in worsened beta cell function. Clofibrate, an agonist of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) delayed the palmitate-induced impairment of AdiR2 expression and PPAR-alpha; this delay was abolished by PPAR-alpha targeted small interfering RNA. The results suggest that AdiR2 expression is regulated by palmitate via PPAR-alpha.
Insights
Adiponectin receptor 2 (AdiR2) expression in beta cells changes with lipid levels, potentially impacting diabetes. Peroxisome proliferator-activated receptor-alpha (PPAR-alpha) influences this regulation.
Area of Science:
- Endocrinology
- Metabolic Research
- Diabetes Pathophysiology
Background:
- Adiponectin receptors are key to adiponectin's antidiabetic actions.
- Their expression in pancreatic beta cells, crucial for diabetes, remains largely uncharacterized.
- Adiponectin receptor 2 (AdiR2) is investigated due to its potential role in beta cell function.
Purpose of the Study:
- To investigate the expression of adiponectin receptor 2 (AdiR2) in beta cells.
- To determine how hyperlipidemic conditions affect AdiR2 expression in beta cells.
- To elucidate the regulatory mechanisms, including the role of peroxisome proliferator-activated receptor-alpha (PPAR-alpha), in AdiR2 expression.
Main Methods:
- Quantitative analysis of AdiR2 expression in beta cells under varying lipid conditions.
- Treatment with clofibrate (PPAR-alpha agonist) and palmitate.
- Use of small interfering RNA (siRNA) targeting PPAR-alpha to assess regulatory pathways.
Main Results:
- AdiR2 expression was elevated under acute hyperlipidemic conditions but reduced under chronic conditions.
- Impaired AdiR2 expression correlated with diminished beta cell function.
- Clofibrate treatment delayed palmitate-induced impairment of AdiR2 and PPAR-alpha expression.
- PPAR-alpha targeted siRNA abolished the protective effect of clofibrate.
Conclusions:
- Beta cell AdiR2 expression is dynamically regulated by lipid exposure.
- Chronic hyperlipidemia impairs AdiR2 expression, potentially contributing to beta cell dysfunction in diabetes.
- The findings suggest a regulatory role for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in mediating the effects of palmitate on AdiR2 expression in beta cells.
More Related Videos
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
GPCRs Regulate Adenylyl Cylase Activity
Two...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
Regulation of Food Intake

